Free Trial

Nutanix (NTNX) Stock Forecast & Price Target

Nutanix logo
$65.07 +1.17 (+1.83%)
(As of 12/20/2024 05:40 PM ET)

Nutanix - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
3
Buy
14

Based on 17 Wall Street analysts who have issued ratings for Nutanix in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 17 analysts, 3 have given a hold rating, and 14 have given a buy rating for NTNX.

Consensus Price Target

$79.47
22.12% Upside
According to the 17 analysts' twelve-month price targets for Nutanix, the average price target is $79.47. The highest price target for NTNX is $90.00, while the lowest price target for NTNX is $70.00. The average price target represents a forecasted upside of 22.12% from the current price of $65.07.
Get the Latest News and Ratings for NTNX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Nutanix and its competitors.

Sign Up

NTNX Analyst Ratings Over Time

TypeCurrent Forecast
12/23/23 to 12/22/24
1 Month Ago
11/23/23 to 11/22/24
3 Months Ago
9/24/23 to 9/23/24
1 Year Ago
12/23/22 to 12/23/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
14 Buy rating(s)
13 Buy rating(s)
11 Buy rating(s)
10 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
4 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$79.47$73.86$73.31$49.45
Forecasted Upside22.12% Upside0.93% Upside20.06% Upside4.69% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

NTNX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

NTNX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Nutanix Stock vs. The Competition

TypeNutanixComputer and Technology CompaniesS&P 500
Consensus Rating Score
2.82
2.69
2.51
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside22.12% Upside265.04% Upside14.53% Upside
News Sentiment Rating
Neutral News

See Recent NTNX News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/17/2024Morgan Stanley
3 of 5 stars
 Boost TargetOverweight ➝ Overweight$78.00 ➝ $85.00+28.22%
12/12/2024UBS Group
4 of 5 stars
J. Hickey
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$81.00+25.04%
11/27/2024Wells Fargo & Company
3 of 5 stars
 Boost TargetEqual Weight ➝ Equal Weight$60.00 ➝ $75.00+10.73%
11/27/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$77.00 ➝ $83.00+19.00%
11/27/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$75.00 ➝ $87.00+14.41%
11/27/2024Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$80.00 ➝ $90.00+24.40%
11/27/2024Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMarket Perform ➝ Market Perform$74.00 ➝ $77.00+6.43%
11/13/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$80.00+10.74%
8/29/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$70.00 ➝ $75.00+21.40%
8/29/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$76.00 ➝ $85.00+62.55%
8/29/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$65.00 ➝ $75.00+43.43%
8/29/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$72.00 ➝ $75.00+43.43%
5/30/2024Northland Capmk
Subscribe to MarketBeat All Access for the recommendation accuracy rating
N. Chokshi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
5/30/2024KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$69.00 ➝ $79.00+7.79%
4/10/2024Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetPositive ➝ Positive$60.00 ➝ $75.00+16.28%
2/5/2024JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Outperform ➝ Market Outperform$50.00 ➝ $70.00+22.70%
1/17/2024William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Ader
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform
5/18/2023OTR Global
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradePositive

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 09:40 AM ET.


NTNX Forecast - Frequently Asked Questions

According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for Nutanix is $79.47, with a high forecast of $90.00 and a low forecast of $70.00.

17 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nutanix in the last year. There are currently 3 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" NTNX shares.

According to analysts, Nutanix's stock has a predicted upside of 22.12% based on their 12-month stock forecasts.

Over the previous 90 days, Nutanix's stock had 1 upgrade by analysts.

Nutanix has been rated by research analysts at Barclays, Morgan Stanley, Needham & Company LLC, Northland Securities, Oppenheimer, Piper Sandler, UBS Group, and Wells Fargo & Company in the past 90 days.

Analysts like Nutanix more than other "computer and technology" companies. The consensus rating score for Nutanix is 2.82 while the average consensus rating score for "computer and technology" companies is 2.69. Learn more on how NTNX compares to other companies.


This page (NASDAQ:NTNX) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners